Recombinant Antibodies

Filter Products By Close
View as Grid List

6 Items

per page
Set Descending Direction
  1. Alemtuzumab Biosimilar - Research Grade
    Rating:
    100%
    $120.00 - $5,000.00
  2. Panitumumab Biosimilar - Research Grade
    Rating:
    100%
    $300.00 - $5,000.00
  3. Atezolizumab Biosimilar - Research Grade
    Rating:
    100%
    $120.00 - $5,000.00
  4. Denosumab Biosimilar - Research Grade
    Rating:
    100%
    $300.00 - $5,000.00
  5. Urelumab Biosimilar - Research Grade
    Rating:
    100%
    $300.00 - $5,000.00
  6. Rituximab Biosimilar N297A Research Grade
    Rating:
    100%
    $300.00 - $5,000.00
View as Grid List

6 Items

per page
Set Descending Direction
Back to Top